MLSC portfolio company Sample6 Secures $11M in Series B Financing to support commercialization of company’s food safety products
October 9, 2013
Sample6, a past Life Sciences Accelerator Loan recipient, announced on October 9, 2013, that the company has secured $11 million in Series B financing to support the commercialization of its food safety products.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.